{"id":438738,"title":"Draft guidance on proposed new Clinical Trials Regulations (GUI-0100) - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-02","captureTimestamp":"2026-01-02T20:17:30.989000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/programs/consultation-modernizing-framework-clinical-trials/draft-guidance-proposed-new-regulations-gui-0100.html?wbdisable=true","snippet":"Draft guidance on proposed new Clinical Trials Regulations (GUI-0100) This draft guidance is for consultation only. For current guidance please see the existing guidance document: Part C, Division 5 of the Food and Drug Regulations “Drugs for Clinical Trials Involving Human…","rawSnapshotUrl":"/api/snapshots/raw/438738","browseUrl":"https://replay.healtharchive.ca/job-6/20260102201730/https://www.canada.ca/en/health-canada/programs/consultation-modernizing-framework-clinical-trials/draft-guidance-proposed-new-regulations-gui-0100.html?wbdisable=true#ha_snapshot=438738","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}